BOXED O
WARNING O
: O
Abrupt B-OSE_Labeled_AE
discontinuation I-OSE_Labeled_AE
of I-OSE_Labeled_AE
intrathecal I-OSE_Labeled_AE
baclofen I-OSE_Labeled_AE
, O
regardless O
of O
the O
cause O
, O
has O
resulted O
in O
sequelae O
that O
include O
high B-NonOSE_AE
fever I-NonOSE_AE
, O
altered B-NonOSE_AE
mental I-NonOSE_AE
status I-NonOSE_AE
, O
exaggerated B-NonOSE_AE
rebound I-NonOSE_AE
spasticity I-NonOSE_AE
, O
and O
muscle B-NonOSE_AE
rigidity I-NonOSE_AE
, O
that O
in O
rare O
cases O
has O
advanced O
to O
rhabdomyolysis B-NonOSE_AE
, O
multiple B-NonOSE_AE
organ I-NonOSE_AE
- I-NonOSE_AE
system I-NonOSE_AE
failure I-NonOSE_AE
and O
death B-NonOSE_AE
. O

Prevention O
of O
abrupt O
discontinuation O
of O
intrathecal O
baclofen O
requires O
careful O
attention O
to O
programming O
and O
monitoring O
of O
the O
infusion O
system O
, O
refill O
scheduling O
and O
procedures O
, O
and O
pump O
alarms O
. O

Patients O
and O
caregivers O
should O
be O
advised O
of O
the O
importance O
of O
keeping O
scheduled O
refill O
visits O
and O
should O
be O
educated O
on O
the O
early O
symptoms O
of O
baclofen B-NonOSE_AE
withdrawal I-NonOSE_AE
. O

Special O
attention O
should O
be O
given O
to O
patients O
at O
apparent O
risk O
( O
e.g O
. O

spinal B-Not_AE_Candidate
cord I-Not_AE_Candidate
injuries I-Not_AE_Candidate
at I-Not_AE_Candidate
T I-Not_AE_Candidate
- I-Not_AE_Candidate
6 I-Not_AE_Candidate
or I-Not_AE_Candidate
above I-Not_AE_Candidate
, O
communication B-Not_AE_Candidate
difficulties I-Not_AE_Candidate
, O
history O
of O
withdrawal B-Not_AE_Candidate
symptoms I-Not_AE_Candidate
from I-Not_AE_Candidate
oral I-Not_AE_Candidate
or I-Not_AE_Candidate
intrathecal I-Not_AE_Candidate
baclofen I-Not_AE_Candidate
) O
. O

Consult O
the O
technical O
manual O
of O
the O
implantable O
infusion O
system O
for O
additional O
postimplant O
clinician O
and O
patient O
information O
( O
see O
WARNINGS O
) O
. O

